CORD-19:02d18b4f484a0420c21595a95b8765125d4a484c / 29201-29486
Annnotations
CORD-19_Custom_license_subset
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T169 | 0-285 | Sentence | denotes | The latter harmful effects may be due to the artifacts of transgenic gene overexpression, since utilizing recombinant ACE2 protein for therapeutic models has been recently shown to be beneficial in various disease models (Oudit et al., 2010; Treml et al., 2010; Wysocki et al., 2010) . |
CORD-19-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T169 | 0-285 | Sentence | denotes | The latter harmful effects may be due to the artifacts of transgenic gene overexpression, since utilizing recombinant ACE2 protein for therapeutic models has been recently shown to be beneficial in various disease models (Oudit et al., 2010; Treml et al., 2010; Wysocki et al., 2010) . |
TextSentencer_T169 | 0-285 | Sentence | denotes | The latter harmful effects may be due to the artifacts of transgenic gene overexpression, since utilizing recombinant ACE2 protein for therapeutic models has been recently shown to be beneficial in various disease models (Oudit et al., 2010; Treml et al., 2010; Wysocki et al., 2010) . |
Epistemic_Statements
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T62 | 0-285 | Epistemic_statement | denotes | The latter harmful effects may be due to the artifacts of transgenic gene overexpression, since utilizing recombinant ACE2 protein for therapeutic models has been recently shown to be beneficial in various disease models (Oudit et al., 2010; Treml et al., 2010; Wysocki et al., 2010) . |